Biofrontera Inc. to Report Third Quarter Financial Results on November 30, 2021
Biofrontera Inc. (Nasdaq: BFRI) will announce its financial results for the three and nine months ending September 30, 2021, before the U.S. markets open on November 30, 2021.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Biofrontera Inc. (Nasdaq: BFRI) will announce its financial results for the three and nine months ending September 30, 2021, before the U.S. markets open on November 30, 2021. The company will host a conference call that day at 4:30 p.m. Eastern time to discuss the results and provide a business update. Biofrontera specializes in dermatological products and focuses on treating conditions such as actinic keratoses and impetigo. Investors can access the live webcast and replay on their website.
Positive
- Upcoming announcement of Q3 2021 financial results may provide investors with insight into company performance.
- Focus on specialized dermatological treatments could indicate a niche market advantage.
Negative
- None.
Details
News Market Reaction – BFRI
The recorded move for BFRI in the trading session of this news was +6.48%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
WOBURN, Mass., Nov. 23, 2021 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, will report financial results for the three and nine months ended September 30, 2021 before the opening of the U.S. financial markets on Tuesday, November 30, 2021 and will hold a conference call that same day beginning at 4:30 p.m. Eastern time to discuss those results and provide a business update.
Conference Call and Webcast Information
| What: | Biofrontera Inc. third quarter 2021 financial results and business update conference call |
| Date: | Tuesday, November 30, 2021 |
| Time: | 4:30 p.m. Eastern time |
| Conference Call: | 1-866-524-3160 (toll free) |
| 1-412-317-6760 (international) | |
| Webcast: | Live and 90-day replay webcast are available at https://investors.biofrontera-us.com/ |
About Biofrontera Inc.
Biofrontera Inc. is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. The Company’s licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. For more information, visit www.biofrontera-us.com.
Contacts
Biofrontera Inc.
Pamela Keck
+1 781 486 1539
us-ir@biofrontera.com
LHA Investor Relations
Tirth T. Patel
+1 212 201 6614
tpatel@lhai.com
# # #
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.